L01EF01 Palbociclib
ATC class of level 5 – chemical substance
This page lists the patient medication information or the product monograph for 5 drugs in this drug class.
- 5 prescription (Rx)
Active ingredient: Palbociclib – all drugs with this active ingredient, also in combination.
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
- L01EF01 Palbociclib 5 drugs
- L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Drugs in the class
| Drug | Rx or OTC |
|---|---|
| Ibrance (Pfizer Canada, Capsule) | prescription (Rx) |
| Ibrance (Pfizer Canada, Tablet) PM | prescription (Rx) |
| Nat-Palbociclib PM | prescription (Rx) |
| PMS-Palbociclib PM | prescription (Rx) |
| Taro-Palbociclib PM | prescription (Rx) |
Other classes of the same level
- L01EF02 Ribociclib 1 drug
- L01EF03 Abemaciclib 1 drug
Other names of the drug class
- English (United Kingdom): L01EF01 palbociclib
- German (Austria): L01EF01 Palbociclib
- Italian: L01EF01 PALBOCICLIB
- Turkish: L01EF01 palbociclib
- Spanish: L01EF01 Palbociclib
- German (Switzerland): L01EF01 Palbociclib
- Italian (Switzerland): L01EF01 Palbociclib
- Dutch: L01EF01 Palbociclib
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EF01
Ask your doctor or pharmacist for advice.